Search

Your search keyword '"Ezhov A."' showing total 163 results

Search Constraints

Start Over You searched for: Author "Ezhov A." Remove constraint Author: "Ezhov A." Topic humans Remove constraint Topic: humans
163 results on '"Ezhov A."'

Search Results

1. The Liver Tumor Segmentation Benchmark (LiTS).

2. World Heart Federation Cholesterol Roadmap 2022

3. Federated learning enables big data for rare cancer boundary detection

4. Projected impact of treatment intensification with statin, ezetimibe, and statin plus ezetimibe fixed-dose combination on MACE across six countries

5. Inclisiran – a new era in lipid-lowering therapy

6. World Heart Federation Cholesterol Roadmap 2022

7. Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice:: GLORIA-AF Registry

8. The Prospective Studies of Atherosclerosis (Proof-ATHERO) Consortium: Design and Rationale

9. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

10. Clinical Characteristics and Factors Associated with Poor Outcomes in Hospitalized Patients with Novel Coronavirus Infection COVID-19

11. Induced pluripotent stem cell line ICGi037-A, obtained by reprogramming peripheral blood mononuclear cells from a patient with familial hypercholesterolemia due to heterozygous p.Trp443Arg mutations in LDLR

12. Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases - A position paper from the International Lipid Expert Panel (ILEP)

13. Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk

14. Geometry-aware neural solver for fast Bayesian calibration of brain tumor models

15. ISLES 2022: A multi-center magnetic resonance imaging stroke lesion segmentation dataset

16. Learn-Morph-Infer: A new way of solving the inverse problem for brain tumor modeling

17. [Weather and climatic factors at the resort of the Southern coast of Crimea in the medical rehabilitation of patients with hypertension]

18. AI-Based Automatic Segmentation of Craniomaxillofacial Anatomy From CBCT Scans for Automatic Detection of Pharyngeal Airway Evaluations in OSA patients

19. Induced pluripotent stem cell line ICGi038-A, obtained by reprogramming peripheral blood mononuclear cells from a patient with familial hypercholesterolemia due to compound heterozygous c.1246C T/c.940 + 3_940 + 6del mutations in LDLR

20. Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation. the GLORIA-AF registry

21. Mercury contamination and potential health risks to Arctic seabirds and shorebirds

22. Extrapolating Long-term Event-Free and Overall Survival With Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis of a Phase 3 Randomized Clinical Trial

23. The Relationship of the Concentration of Lipoprotein(a) and Markers of Inflammation with Multifocal Atherosclerosis in Women

24. Profiles of Little-Known Medicinal Polypores: Haploporus odorus (Agaricomycetes)

25. Meeting Paris agreement objectives will temper seabird winter distribution shifts in the North Atlantic Ocean

26. A deep learning approach for dental implant planning in cone-beam computed tomography images

27. An automatic multi-tissue human fetal brain segmentation benchmark using the Fetal Tissue Annotation Dataset

28. North Atlantic winter cyclones starve seabirds

29. VERSE: A Vertebrae labelling and segmentation benchmark for multi-detector CT images

30. Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries

31. The Role of Nutraceuticals in Statin Intolerant Patients

32. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

33. [The relationship between the level of Lр(а) and the prevalence of atherosclerosis among young patients]

34. Therapeutic Apheresis for Management of Lp(a) Hyperlipoproteinemia

35. [Optimization of lipid-lowering therapy in patients after ischemic stroke. Resolution of the Council of Experts]

36. [Association of lipoprotein (a) with ischemic stroke and stenotic carotid atherosclerosis]

37. Toward a locally adaptive optical protection filtering for human eyes and technical vision sensors

38. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

39. Statin therapy in athletes and patients performing regular intense exercise - Position paper from the International Lipid Expert Panel (ILEP)

40. The association of lipoprotein(a) and apolipoprotein(a) phenotypes with peripheral artery disease

41. Profiles of Little-Known Medicinal Polypores: Funalia trogii (Agaricomycetes)

42. Imaging-Guided Delivery of a Hydrophilic Drug to Eukaryotic Cells Based on Its Hydrophobic Ion Pairing with Poly(hexamethylene guanidine) in a Maleated Chitosan Carrier

43. Association of lipoprotein(a) level with short- and long-term outcomes after CABG: The role of lipoprotein apheresis

44. Peroxyoxalate Chemiluminescent Reaction as a Tool for Elimination of Tumour Cells Under Oxidative Stress

45. ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic Epidemiology

46. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

47. Evaluation of artificial intelligence for detecting periapical pathosis on cone-beam computed tomography scans

48. The Impact of the International Cooperation On Familial Hypercholesterolemia Screening and Treatment: Results from the ScreenPro FH Project

49. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation

50. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation

Catalog

Books, media, physical & digital resources